Unichem Laboratories Ltd share price logo

Unichem Laboratories Ltd Share Price

NSE: UNICHEMLAB

BSE: 506690

Small Cap

Healthcare Sector

466.40

-11.85

(-2.48%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Unichem Laboratories Ltd Stock Performance

as on November 21, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹464.7
    ₹480
    downward going graph

    0.36%

    Downside

    2.92%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹444
    ₹904
    downward going graph

    4.80%

    Downside

    93.83%

    Upside

    downward going graph

Unichem Laboratories Ltd share price movements today

Previous Close
₹478.25
Open
₹473.45
Volume
8,833.00
Upper Circuit
₹573.90
Lower Circuit
₹382.60
Day's Low - High
₹464.7 - ₹480
52 Week Low - High
₹444 - ₹904

Unichem Laboratories Ltd Historical Returns

1 Month Return
+ 2.97 %
3 Month Return
-5.07 %
1 Year Return
-44.43 %
3 Year Return
+ 10.71 %
5 Year Return
+ 91.49 %

Unichem Laboratories Ltd Fundamentals

as on November 21, 2025 at 4:01 pm IST

Market Cap

₹3,367.15 Cr

Return on Equity (ROE)

6.86

PE Ratio (TTM)

38.08

Return on capital employed (ROCE)

7.58

Industry PE ratio

42.05

Beta (LTM)

1

P/B Ratio

1.98

Dividend Yield

0

PEG Ratio

2.27

Quarterly Earnings Growth YOY

-148.27

EPS (TTM)

19.53

Sector

Pharmaceuticals

Book Value

348.1

Technical Analysis

Unichem Laboratories Ltd Stock Valuation

as on November 21, 2025 at 4:01 pm IST

Unichem Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-1720.62x)

October 1, 2021

Today (38.08x)

November 20, 2025

Industry (42.05x)

November 20, 2025

Highest (1039.54x)

February 5, 2024

LowHigh

Today’s Price to Earnings Ratio: 38.08x

Unichem Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unichem Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA3,367.1518.3%0.581372,110
NA36.80-0.99%0.78-1392
BUY6,634.94-9.41%0.533434,118
NA20.9341.68%0.00NA15
NA1,035.4547.65%0.5929405

Unichem Laboratories Ltd Stock’s Investor Sentiment and Interest

Search interest for Unichem Laboratories Ltd Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:26% versus previous 30 day period

Unichem Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
302.5
402.1
423.19
415.63
465.72
431.7
483.34
507.36
533.09
587.18
526.6
578.96
Other Income
16.35
5.11
8.63
5.54
79.28
6.15
3.76
8.69
13.62
9.25
6.82
20.97
Total Income
318.85
407.21
431.82
421.16
545
437.85
487.1
516.05
546.71
596.43
533.42
599.93
Expenses
345.26
419.16
395.17
406.87
434.6
531.97
443.19
451.87
447.57
503.48
504.11
571.04
Operating Profit
-42.76
-17.06
28.02
8.76
31.12
-100.27
40.15
55.49
85.52
83.7
22.49
7.92
Operating Profit Margin %
-14.14%
-4.24%
6.62%
2.11%
6.68%
-23.23%
8.31%
10.94%
16.04%
14.25%
4.27%
1.37%
Profit Before Interest, Tax and Depreciation
-26.41
-11.95
36.65
14.3
110.4
-94.12
43.91
64.18
99.14
92.95
29.31
28.89
Interest
4.09
5.52
5.76
6.73
5.58
4.59
4.03
4.79
6.75
5.46
6.54
8.24
Depreciation
30.78
29.68
28.77
29.45
31.62
27.16
32.07
32.26
30.54
29.69
31.79
31.47
Profit Before Tax
-61.28
-47.15
2.12
-21.88
73.2
-125.87
7.81
27.13
61.85
57.8
-9.02
-10.82
Tax Paid
2.64
-2.89
2.79
2.6
-0.02
3.44
5.74
2.5
4
4.83
1.45
1.07
Profit After Tax
-63.93
-44.27
-0.67
-24.49
73.22
-129.31
2.07
24.63
57.85
52.97
-10.47
-11.89
Total Net profit including share of profit / Loss from associate company
-63.93
-44.27
-0.67
-24.49
73.22
-129.31
2.07
24.63
57.85
52.97
-10.47
-11.89
EPS
-9.08
-6.28
-0.09
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
Actual EPS
-9.08
-6.28
-0.09
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
Adjusted EPS
-9.08
-6.28
-0.09
-3.48
10.39
-18.37
0.29
3.5
8.22
7.52
-1.49
-1.69
Diluted EPS
-9.08
-6.28
-0.09
-3.48
10.39
-18.36
0.29
3.49
8.19
7.5
-1.49
-1.69

Unichem Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
697.71
814.59
1,180.05
1,103.71
1,235.14
1,269.83
1,343.02
1,785.11
2,110.97
Other Income
185.09
2,738.88
100.24
92.13
50.19
47.51
38.52
31.59
35.32
Total Income
882.8
3,553.47
1,280.28
1,195.84
1,285.32
1,317.34
1,381.54
1,816.7
2,146.29
Expenses
739.11
946.71
1,263.54
1,154.53
1,144.37
1,198.1
1,427.14
1,755.84
1,846.11
Operating Profit
-41.4
-132.12
-83.49
-50.82
90.77
71.73
-84.12
29.27
264.86
Operating Profit Margin %
-5.93%
-16.22%
-7.08%
-4.6%
7.35%
5.65%
-6.26%
1.64%
12.55%
Profit Before Interest, Tax and Depreciation
143.7
2,606.77
16.74
41.31
140.95
119.24
-45.61
60.86
300.18
Interest
3.36
8.01
7.52
7.85
5.12
6.11
17.31
22.66
21.03
Depreciation
43.52
50.51
67.37
81.67
84.36
91.17
113.44
123.16
124.56
Profit Before Tax
96.82
2,548.25
-58.15
-48.21
51.47
21.96
-176.36
-84.96
154.59
Tax Paid
-11.85
3.34
-34.35
11.97
17.15
-11.09
25.86
8.8
17.07
Profit After Tax
108.68
2,544.91
-23.8
-60.18
34.32
33.06
-202.23
-93.76
137.52
Total Net profit including share of profit / Loss from associate company
108.68
2,544.91
-23.8
-60.18
34.32
33.06
-202.23
-93.76
137.52
EPS
11.96
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
Actual EPS
11.96
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
Adjusted EPS
11.96
280.6
-3.63
-8.55
4.88
4.7
-28.72
-13.32
19.53
Diluted EPS
11.94
280.41
-3.63
-8.55
4.88
4.68
-28.72
-13.32
19.47

Unichem Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
111.72
68.19
-112.34
-327.77
19.82
32.98
-259.61
-85.09
14
-7.02
Cash Flow from Investing Activities
-85.12
-127.87
1,648.34
-286.01
-35.91
-65.97
100.11
240.94
63.31
-241.91
Cash Flow from Financing Activities
-33.43
59.23
-881.14
-2.42
-62.3
-121.08
191.23
-81.3
-106.31
183.76
Net Cash Flow
-6.84
-0.46
654.86
-616.19
-78.4
-154.06
31.74
74.56
-29
-65.17

Unichem Laboratories Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
50.93%
50.93%
50.93%
70.21%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
70.22%
DII
8.2%
8.16%
7.39%
10.32%
9.29%
11.27%
11.58%
11.67%
11.63%
11.32%
10.92%
10.75%
FII
0%
0%
0%
0.83%
0%
0.9%
0.89%
0.94%
1.06%
0.98%
0.98%
1%
Public
39.3%
39.21%
37.72%
18.64%
18.18%
17.61%
17.3%
17.18%
17.09%
17.48%
17.88%
18.03%
Total Outstanding Shares
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
7,04,05,750
Total Shareholders
30,618
29,418
26,642
21,584
20,877
21,171
20,621
20,374
21,472
21,621
23,010
23,577

Mutual Funds that own Unichem Laboratories Ltd Stock

Check out the Mutual Funds with significant holdings in Unichem Laboratories Ltd.

Unichem Laboratories Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Unichem Laboratories Ltd.

  • Unichem Laboratories Ltd Earnings Results

    Unichem Laboratories Ltd’s net profit fell -148.27% since last year same period to ₹-11.89Cr in the Q2 2025-2026. On a quarterly growth basis, Unichem Laboratories Ltd has generated -13.56% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Unichem Laboratories Ltd Dividends May,2022

    In the quarter ending March 2022, Unichem Laboratories Ltd has declared dividend of ₹4.00 per share on 27 May 2022 - translating a dividend yield of 1.66%.

    Read More about Dividends

Indices Featuring Unichem Laboratories Ltd Stock

Check stock indices that include Unichem Laboratories Ltd.

BSE Healthcare

₹44,395.66

-0.5 (-221.27%)

BSE Small-Cap

₹52,011.66

-1.3 (-683.73%)

Insights on Unichem Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 533.42 Cr → 599.93 Cr (in ₹), with an average increase of 11.1% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 17.88% to 18.03% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, UNICHEMLAB stock has moved up by 2.6%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.98% to 1.00% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 20.0% return, outperforming this stock by 64.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 70.22% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.0% return, outperforming this stock by 118.3%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 9.39% to 9.17% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 57.85 Cr → -11.89 Cr (in ₹), with an average decrease of 47.3% per quarter

About Unichem Laboratories Ltd

Unichem Laboratories Ltd is an India based pharmaceutical company, headquartered in Mumbai, specialising in the manufacture of active pharmaceutical ingredients (API). Founded in 1962, the company has five manufacturing facilities in Roha, Maharashtra; Goa; Ghaziabad, Uttar Pradesh; Pithampur, Madhya Pradesh; and Baddi, Himachal Pradesh, all of which have been certified ISO 9001:2000 and ISO 14001:2004. Over the years, Unichem Laboratories Ltd has formed collaborations and acquired subsidiaries such as Uni Sankyo Co.Marketing Formulations, Medical Corporation South Africa, Unisearch Ltd., Niche Generics Ltd., and Unichem Pharmaceuticals USA Inc. In 2019, they set up their first subsidiary in China, Younikaimo Pharmaceutical Shanghai Private Limited. The company recently sold their domestic formulations business, and manufacturing facility at Sikkim, on a going concern basis, to Torrent Pharmaceuticals Limited. They remain at the forefront of the pharmaceutical industry with their commitment to innovation and quality.

Revenue: ₹578.96Cr as on September 2025 (Q2 FY26)
Net Profit: ₹-11.89Cr as on September 2025 (Q2 FY26)
Listing date: 10 Jan, 1995
Chairperson Name: Prakash A Mody
OrganisationUnichem Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPrakash A Mody
E-voting on sharesClick here to vote

FAQs

What is Unichem Laboratories Ltd share price today?

Unichem Laboratories Ltd share price today stands at ₹466.4 as on at the close of the market. Unichem Laboratories Ltd share today touched a day high of ₹480 and a low of ₹464.7.

What is the 52 week high and 52 week low range for Unichem Laboratories Ltd share?

Unichem Laboratories Ltd touched a 52 week high of ₹904 and a 52 week low of ₹444. Unichem Laboratories Ltd share price today i.e. is closed at ₹466.4, which is -48.41% down from its 52 week high and 5.05% up from its 52 week low.

What is Unichem Laboratories Ltd's market capitalisation today?

Unichem Laboratories Ltd market capitalisation is ₹3,367.15 Cr as on .

How to buy Unichem Laboratories Ltd shares?

To buy Unichem Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for UNICHEMLAB or Unichem Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Unichem Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Unichem Laboratories Ltd trading volume today?

Unichem Laboratories Ltd trading volume is 8,833.00 as on . This means that 8,833.00 shares of Unichem Laboratories Ltd were bought and sold on the stock market during today's trading session.